Brian Joseph Cahill - 30 Jan 2023 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Chief Financial Officer
Signature
/s/ Brian Cahill
Issuer symbol
EGRX
Transactions as of
30 Jan 2023
Net transactions value
-$19,959
Form type
4
Filing time
31 Jan 2023, 17:21:59 UTC
Previous filing
09 Jan 2023
Next filing
06 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability $19,959 -601 -1.9% $33.21 30,871 30 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The disposition reported on this Form 4 represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units.